Items where authors include "Harland, M."

Article

Giryes, S. orcid.org/0000-0002-4105-3550, Wong, C., Bridgewood, C. et al. (12 more authors) (2025) Paradoxical Activation of Entheseal Myeloid Cells by JAK1 and TYK2 Inhibitors via IL10 Antagonism. Arthritis & Rheumatology. ISSN 2326-5191

Randerson-Moor, J., Davies, J., Harland, M. et al. (10 more authors) (2024) Systemic inflammation, the peripheral blood transcriptome and primary melanoma. Journal of Investigative Dermatology, 144 (11). 2513-2529.e17. ISSN 0022-202X

Björk, J.R., Bolte, L.A., Maltez Thomas, A. et al. (37 more authors) (2024) Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma. Nature Medicine, 30. pp. 785-796. ISSN 1078-8956

Sun, G., Davies, J.R. orcid.org/0009-0002-4272-2477, Mell, T. et al. (7 more authors) (2024) APOE genotype, eicosapentaenoic acid (EPA) supplementation and n-3 highly unsaturated fatty acid (HUFA) levels in patients with multiple colorectal polyps: A secondary analysis of the seAFOod polyp prevention trial. Prostaglandins Leukotrienes and Essential Fatty Acids, 201. 102623. ISSN 0952-3278

Davies, J.R. orcid.org/0009-0002-4272-2477, Mell, T. orcid.org/0009-0001-6744-1340, Fuller, H. orcid.org/0000-0001-8381-519X et al. (10 more authors) (2023) Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial. Cancer Prevention Research, 16 (11). pp. 621-630. ISSN 1940-6207

Davies, J.R. orcid.org/0009-0002-4272-2477, Mell, T. orcid.org/0009-0001-6744-1340, Fuller, H. orcid.org/0000-0001-8381-519X et al. (10 more authors) (2023) Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial. Cancer Prevention Research, 16 (11). pp. 621-630. ISSN 1940-6207

Ganguly, P. orcid.org/0000-0003-1042-5910, Macleod, T., Wong, C. et al. (2 more authors) (2023) Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in Inflammatory Arthritis: A Narrative of the Emergence of MAPK-Activated Protein Kinase Inhibitors (MK2i). Pharmaceuticals, 16 (9). 1286. ISSN 1424-8247

Proceedings Paper

Caley, L.R. orcid.org/0000-0001-8957-1018, Wood, H., de Goaffau, M.C. et al. (5 more authors) (2025) EPS4.06Antibiotic resistance genes in stool samples from adults with cystic fibrosis: preliminary analysis. In: Journal of Cystic Fibrosis. 48th European Cystic Fibrosis Conference, 04-07 Jun 2025, Milan, Italy. Elsevier .

Caley, L.R. orcid.org/0000-0001-8957-1018, de Goffau, M., Marsh, R. et al. (8 more authors) (2024) WS04.03 Associations between nutrient intake, SCFA levels and the faecal microbiota in adults with cystic fibrosis: preliminary analysis. In: Journal of Cystic Fibrosis. 47th European Cystic Fibrosis Conference, 05 Jun 2024 - 08 Jun 2025, Glasgow, UK. Elsevier .

Pike, A., Fox, N., McKinley, C.E. orcid.org/0000-0003-4006-8846 et al. (22 more authors) (2023) Sars-Cov-2 Antibody and T-Cell Responses in Patients with Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia after Four COVID-19 Vaccinations. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, CA, USA. American Society of Hematology , p. 2712.